Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Emmaus Life Sciences, Inc. (EMMA) had Profit Margin of -96.84% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.41M |
|
$-2.33M |
|
$0.23M |
|
$2.18M |
|
$3.39M |
|
$-0.98M |
|
$-1.35M |
|
$-2.33M |
|
$-2.33M |
|
$-2.33M |
|
$-2.33M |
|
$-2.33M |
|
$-2.33M |
|
$-0.98M |
|
$-0.88M |
|
63.87M |
|
63.87M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$5.65M |
|
$0.04M |
|
$16.82M |
|
$22.48M |
|
$64.92M |
|
$2.25M |
|
$16.16M |
|
$81.08M |
|
$-58.60M |
|
$-58.60M |
|
$-58.60M |
|
63.87M |
|
| Cash Flow Statement Financials | |
$0.28M |
|
-- |
|
$-0.34M |
|
$1.39M |
|
$1.33M |
|
$-0.06M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-0.04 |
|
-0.51 |
|
90.65% |
|
-40.73% |
|
-40.73% |
|
-- |
|
-96.67% |
|
|
Profit Margin |
-96.84% |
$0.28M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.16 |
|
1.17 |
|
77.09 |
|
3.98% |
|
3.98% |
|
-10.37% |
|
4.13% |
|
$-0.92 |
|
$0.00 |
|
$0.00 |
|